Abdi İbrahim Wins Awards in 5 Categories

Abdi İbrahim Awarded in Five Categories Abdi İbrahim received awards in five categories at the Crystal Mortar Awards presented by the Association of Chemists. Moving with a mission to improve lives for 111 years, Abdi İbrahim was recognized in five categories at the Crystal Mortar Awards given within the scope of the 11th International Pharmaceutical Chemistry Congress, based on its research and development activities and investments. On the opening day of the 11th International Pharmaceutical Chemistry Congress held in Antalya this year by the Association of Chemists, pharmaceutical companies' research and development work was recognized in seven categories. Abdi İbrahim won awards in five categories, including "Pharmaceutical Company with the Highest R&D Investment."

"We continue to accelerate our R&D investments"

Udaya Dude, R&D Director at Abdi İbrahim, noted that the company is among those making the most R&D investments in Turkey and stated: "At the center of our research and development and innovation work are high-technology products with high added value that we believe will give our company a competitive advantage in national and international markets. Our efforts continue uninterrupted to develop products and business models that differentiate us from competitors in consumer health, and to produce our own biotechnology-based pharmaceuticals in the biotechnology field. Our R&D vision plays a major role in these efforts. Our R&D center has the capability and infrastructure to develop pharmaceuticals using inhalation technology and nanotechnological methods in order to respond to the changing and evolving needs of the national and international pharmaceutical industry. Along with projects conducted within the company, we carry out know-how transfers through collaborative projects with scientific institutions domestically and internationally. Within the framework of our vision of taking new steps toward the future of our country and the pharmaceutical sector, we will continue to accelerate our R&D work. We are both pleased and motivated to do better by seeing our investments in this field crowned with awards at such prestigious organizations," he said. The categories in which Abdi İbrahim won awards are as follows: • 2021 pharmaceutical companies with the highest R&D expenditure, • 2021 pharmaceutical companies producing the most projects in R&D centers, • 2021 pharmaceutical companies employing the most personnel in R&D centers, • 2021 number of female staff assigned to R&D centers, • 2021 number of master's and doctoral degree holders assigned to R&D centers.